Nemes Rush Group’s Halozyme HALO Stock Holding History

Nemes Rush Group’s Portfolio HALO Stock Details HALO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2	Closed	-$135	–	983
2025 Q4	$135	Buy	+2	New	+$135	﹤0.01%	952
2023 Q4	–	Sell	-20	Closed	-$764	–	671
2023 Q3	$764	Buy	+20	New	+$819	﹤0.01%	604

Other funds holding HALO

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

William Blair Investment Management Chicago, Illinois $33.3B AUM 44.76% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nemes Rush Group's HALO Position: Q1 2026 in Review

Nemes Rush Group sold out of Halozyme (HALO) in Q1 2026, closing a stake of 2 shares — an estimated $135 sold.

Nemes Rush Group first reported a position in HALO in Q3 2023 and held it in 2 quarters. The position peaked at $764 in Q3 2023. 636 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

Nemes Rush Group reported no remaining Halozyme position as of Q1 2026 after selling out during the quarter.
Nemes Rush Group sold 2 Halozyme shares in Q1 2026, an estimated $135.
Nemes Rush Group first reported a position in Halozyme in Q3 2023 and held it in 2 quarters.
Nemes Rush Group's Halozyme position peaked at $764 in Q3 2023.
636 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on Nemes Rush Group's 13F filing for Q1 2026, filed 21 Apr 2026.